PPA
QTTB icon

Parametric Portfolio Associates’s Q32 Bio QTTB Stock Holding History

Parametric Portfolio Associates’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$79K Sell
1,443
-959
-40% -$59.6K ﹤0.01% 3590
2021
Q4 		$157K Buy
+2,402
New +$233K ﹤0.01% 3471
2021
Q3 		– Sell
-1,511
Closed -$198K – 3672
2021
Q2 		$198K Sell
1,511
-864
-36% -$108K ﹤0.01% 3408
2021
Q1 		$402K Sell
2,375
-21
-0.9% -$4.42K ﹤0.01% 3597
2020
Q4 		$487K Buy
+2,396
New +$463K ﹤0.01% 3394
2020
Q3 		– Sell
-1,245
Closed -$340K – 3977
2020
Q2 		$340K Sell
1,245
-511
-29% -$136K ﹤0.01% 3418
2020
Q1 		$491K Sell
1,756
-1
-0.1% -$306 ﹤0.01% 3173
2019
Q4 		$655K Buy
1,757
+236
+16% +$67.6K ﹤0.01% 3267
2019
Q3 		$495K Buy
1,521
+587
+63% +$200K ﹤0.01% 3348
2019
Q2 		$329K Buy
934
+20
+2% +$7.86K ﹤0.01% 3537
2019
Q1 		$456K Sell
914
-178
-16% -$79.6K ﹤0.01% 3389
2018
Q4 		$440K Sell
1,092
-251
-19% -$94.9K ﹤0.01% 3373
2018
Q3 		$552K Buy
1,343
+232
+21% +$78.8K ﹤0.01% 3374
2018
Q2 		$408K Buy
+1,111
New +$398K ﹤0.01% 3424

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Parametric Portfolio Associates's QTTB Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Q32 Bio (QTTB) stake by 40% in Q1 2022, selling an estimated $59.6K and leaving 1,443 shares worth $79K. The position accounts for ﹤0.01% of the portfolio, ranked #3590.

Parametric Portfolio Associates first reported a position in QTTB in Q2 2018 and has held it in 14 quarters since. The position peaked at $655K in Q4 2019. 106 funds tracked by Wall St. Rank hold QTTB as of Q1 2022.

  • Parametric Portfolio Associates held 1,443 shares of Q32 Bio worth $79K as of Q1 2022.
  • Parametric Portfolio Associates sold 959 Q32 Bio shares in Q1 2022, an estimated $59.6K.
  • Q32 Bio made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3590 holding.
  • Parametric Portfolio Associates first reported a position in Q32 Bio in Q2 2018 and has held it in 14 quarters since.
  • Parametric Portfolio Associates's Q32 Bio position peaked at $655K in Q4 2019.
  • 106 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.